Anest. intenziv. Med. 2015;26(3):152-155

Biological treatment and the risk of perioperative complicationsAnaesthesiology - Review articles

O. Gimunová1,*, O. Bednařík2, ©. Forejtová3
1 Klinika anesteziologie, resuscitace a intenzivní medicíny, FN Brno, LF MU
2 Interní hematologická a onkologická klinika, FN Brno, LF MU
3 Revmatologický ústav, Praha

So far, there is no consensus whether to stop biological treatment prior to elective surgery. The results of retrospective studies are very heterogeneous, because the retrospective study design and the relatively small numbers of individuals studied considerably limit the interpretation of the data. The risk of infection is greatest at the beginning of the administration of biological treatment. Current recommendations are in favour of interrupting biological treatment in the perioperative period. We present a recommendation on the management of biological treatment before surgery.

Keywords: biological treatment; perioperative period; infection

Received: January 18, 2015; Accepted: March 15, 2015; Published: June 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gimunová O, Bednařík O, Forejtová ©. Biological treatment and the risk of perioperative complications. Anest. intenziv. Med. 2015;26(3):152-155.
Download citation

References

  1. Doran, M. F., Crowson, C. S., Pond, G. R., O'Fallon, W. M., Gabriel, S. E. Frequency of infection in patients with rheumatoid arthritis compared with controls: A population-based study. Arthritis Rheum., 2002, 46, p. 2287-2293. Go to original source... Go to PubMed...
  2. Goh, L., Jewell, T., Laversuch, C., Samanta, A. Should anti-TNF therapy be discontinued in rheumatoid arthritis patients undergoing elective orthopaedic surgery? A systematic review of the evidence. Rheumatol. Int., 2012, 32, p. 5-13. Go to original source... Go to PubMed...
  3. Listing, J., Gerhold, K., Zink, A. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatology, 2013, 52, p. 53-61. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.